JBQ · Class II · 21 CFR 864.7060

FDA Product Code JBQ: Antithrombin Iii Quantitation

Leading manufacturers include Siemens Healthcare Diagnostic Products GmbH.

56
Total
56
Cleared
102d
Avg days
1977
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period
Review times increasing: avg 184d recently vs 100d historically

FDA 510(k) Cleared Antithrombin Iii Quantitation Devices (Product Code JBQ)

56 devices
1–24 of 56

About Product Code JBQ - Regulatory Context

510(k) Submission Activity

56 total 510(k) submissions under product code JBQ since 1977, with 56 receiving FDA clearance (average review time: 102 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under JBQ have taken an average of 184 days to reach a decision - up from 100 days historically. Manufacturers should account for longer review timelines in current project planning.

JBQ devices are reviewed by the Hematology panel. Browse all Hematology devices →